— Know what they know.
Not Investment Advice

NYR.AX ASX

Nyrada Inc.
1W: +0.0% 1M: -27.8% 3M: +23.8% YTD: -35.8% 1Y: +100.0% 3Y: +1900.0% 5Y: +85.7%
A$0.51 ($0.35)
+0.01 (+2.00%)
 
Weekly Expected Move ±13.4%
A$0 A$0 A$1 A$1 A$1
ASX · Healthcare · Biotechnology · Tech Score Strong Sell · Power 35 · A$126.5M mcap · 130M float · 0.237% daily turnover

Income Trends

Revenue
$0 -100.0% ▼
Gross Profit
-$3K +99.8% ▲
Operating Income
-$9M +6.8% ▲
Net Income
-$7M -34.7% ▼
EPS (Diluted)
$-0.03 -12.8% ▼
EBITDA
-$9M -71.3% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$1M$1M$3M$2M$0
YoY Growth-53.2%+30.7%+126.7%-26.1%-100.0%
Cost of Revenue$5K$7K$2M$4M$3K
Gross Profit$1M$1M-$814K-$2M-$3K
Gross Margin99.6%99.5%-25.1%-82.6%—
R&D Expenses$2M$6M$2M$4M$3M
SG&A Expenses$3M$3M$3M$3M$5M
Operating Expenses$5M$9M$5M$7M$9M
Operating Income-$5M-$14M-$5M-$9M-$9M
Operating Margin-444.5%-985.0%-140.7%-383.9%—
Interest Expense$1K$0$0$0$0
Income Before Tax-$5M-$8M-$5M-$5M-$9M
Tax Expense-$1M-$1M-$3M-$2M-$2M
Net Income-$4M-$8M-$1M-$5M-$7M
Net Margin-363.3%-546.6%-42.8%-202.2%—
EPS (Diluted)$-0.03$-0.05$-0.01$-0.02$-0.03
EBITDA-$5M-$9M-$5M-$5M-$9M
Shares Outstanding156M156M163M200M239M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms